Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
DR. HILDE LUYTEN, REUMATOLOOG from Gent, company number BE0686842350, closed financial year 2025 with a result of € 152,329 after tax. For that financial year DR. HILDE LUYTEN, REUMATOLOOG recorded a gross margin of € 217,975 and equity of € 18,660. Compared with financial year 2024, the result moved from € 149,464 to € 152,329. Profitable, and profit is growing. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on December 12, 2025.
€ 18,660
▼ 3% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 152,329
▲ 2% vs 2024
Profit after tax over the fiscal year.
€ 106,845
▲ 37% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 153,000 paid out
100 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 53,751
▼ 25% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 2,036
▲ 88% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 1,541
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 148,384 | € 173,266 | € 210,241 | € 217,975 | ▲ 4% |
| Profit after taxes | € 107,731 | € 128,885 | € 149,464 | € 152,329 | ▲ 2% |
| Equity | € 131,982 | € 22,867 | € 19,331 | € 18,660 | ▼ 3% |
| Total debts | € 9,657 | € 133,083 | € 157,588 | € 160,928 | ▲ 2% |
| Cash | € 133,235 | € 151,042 | € 78,000 | € 106,845 | ▲ 37% |
| Retained profit | € 113,382 | € 4,267 | € 731 | € 60 | ▼ 92% |
| Dividend | € 247,000 | € 238,000 | € 153,000 | € 153,000 | |
| Balance sheet total | € 141,639 | € 155,950 | € 176,919 | € 179,588 | ▲ 2% |
Key figures of DR. HILDE LUYTEN, REUMATOLOOG, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.
What happened to DR. HILDE LUYTEN, REUMATOLOOG?
What happened at DR. HILDE LUYTEN, REUMATOLOOG in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 152,329 (▲ 2% vs 2024). Source: NBB ↗
- New establishment in Gent. KBO
- Start of the company according to the CBE. KBO
In short
From € 107,731 profit in 2022 to € 152,329 profit in 2025.
Paid € 161,323 in corporate taxes since 2022.
Best year ever: 2025, with € 152,329 profit.
Paid out € 791,000 in dividends to the owners in total.
Management
Behind DR. HILDE LUYTEN, REUMATOLOOG is Hilde Luyten.
Directors
According to the 2025 annual accounts
Hilde Luyten
Director
Establishments
Establishment units
Physical locations of this company
Gentstraat 3
9041 Gent
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0686.842.350
- VAT number
- BE 0686.842.350
- Registered office
- Gentstraat 3, 9041 Gent
- Names & denominations
- DR. HILDE LUYTEN, REUMATOLOOG
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 26 December 2017
- Peppol
- Not registered